Contraceptive Implant Use Rising Despite Remaining Below Other Birth Control Methods
Contraceptive implants, the most effective reversible birth control method available, are seeing increased provision and utilization in the United States, though adoption rates remain lower than other contraceptive methods. The growth in implant use reflects evolving clinical practice patterns and improved access channels. For Medicaid managed care organizations, implants represent a covered preventive service under federal requirements, with reimbursement structures varying by state. The shift toward long-acting reversible contraceptives has implications for pharmacy benefit management, provider network adequacy, and quality metrics related to reproductive health access.
Medicaid MCOs must ensure network capacity for implant insertion and removal, navigate state-specific reimbursement models that may bundle or separate device and procedure costs, and track contraceptive access metrics that increasingly include LARC availability as a quality measure.
Maternal · Managed Care · Pharmacy
You might also like